Single nucleotide polymorphisms (SNPs) in TMEM106B have since been identified as risk modifiers for a variety of neurodegenerative diseases including AD, hippocampal sclerosis (HS), and Parkinson's disease (PD).18, 24, 29, 30, 31, 32. This evidence concerns the gene TMEM106B and neurodegenerative disease.